First void urine & HPV genotyping
Webinar organized with Novosanis
The enormous potential of a first void – or initial stream – urine sample becomes evident when we understand its composition. In fact, in the case of women a first void urine sample could also be called “A genital sample collected by urination”.
In this webinar Prof Alex Vorsters presented his understanding in this field leading to the development of the Colli-Pee® urine collection device. Data were presented, confirming that improved collection of a first void urine sample as well as its immediate preservation have a major impact on HPV DNA detection. Further to that, the results from a large HPV vaccination follow-up study were discussed. For monitoring HPV vaccination trials, the use of a sensitive and full individual genotyping assay such as the INNO-LiPA® HPV Genotyping Extra II, provides important information on the impact of the vaccination program.
Watch the replay below.
First void urine & HPV genotyping - Two essential tools to monitor the impact of HPV vaccination programs
Topics covered:
- Data confirming that improved collection of a first void urine sample as well as its immediate preservation have a major impact on HPV DNA detection
- Results from large HPV vaccination follow-up study
- Important information on the impact of the vaccination program, provided by the use of a sensitive and full individual genotyping assay such as the INNO-LiPA HPV genotyping Extra II.
A panel with Prof Alex Vorsters, accompanied by David Faster of Novosanis and Rebecca Millecamps of Fujirebio answered questions from participants.
